Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Research

GPs’ and pharmacists’ views of integrating pharmacists into general practices: a qualitative study

Ameerah S Hasan Ibrahim, Heather E Barry and Carmel M Hughes
British Journal of General Practice 2023; 73 (731): e407-e417. DOI: https://doi.org/10.3399/BJGP.2022.0518
Ameerah S Hasan Ibrahim
Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan, and researcher, Primary Care Research Group, School of Pharmacy, Queen’s University Belfast, Belfast, UK.
MSc Pharm, PhD
Roles: Assistant professor in clinical pharmacy and pharmacy practice
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ameerah S Hasan Ibrahim
Heather E Barry
School of Pharmacy, Queen’s University Belfast, Belfast, UK.
MPharm, PhD, MRPharmS, MPSNI
Roles: Lecturer in pharmacy practice
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heather E Barry
Carmel M Hughes
School of Pharmacy, Queen’s University Belfast, Belfast, UK.
PhD, MRPharmS, MPSNI
Roles: Professor of primary care pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carmel M Hughes
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Abstract

Background Practice-based pharmacists (PBPs) have been introduced into general practice across the UK to relieve some of the pressures within primary care. However, there is little existing UK literature that has explored healthcare professionals’ (HCPs’) views about PBP integration and how this role has evolved.

Aim To explore the views and experiences of GPs, PBPs, and community pharmacists (CPs) about PBPs’ integration into general practice and their impact on primary healthcare delivery.

Design and setting A qualitative interview study in primary care in Northern Ireland.

Method Purposive and snowball sampling were used to recruit triads (a GP, a PBP, and a CP) from across five administrative healthcare areas in Northern Ireland. Sampling of practices to recruit GPs and PBPs commenced in August 2020. These HCPs identified the CPs who had most contact with the general practices in which the recruited GPs and PBPs were working. Semi-structured interviews were recorded, transcribed verbatim, and analysed using thematic analysis.

Results Eleven triads were recruited from across the five administrative areas. Four main themes in relation to PBPs’ integration into general practices were revealed: evolution of the role; PBP attributes; collaboration and communication; and impact on care. Areas for development were identified such as patient awareness of the PBP role. Many saw PBPs as a ‘central hub–middleman’ between general practice and community pharmacies.

Conclusion Participants reported that PBPs had integrated well and perceived a positive impact on primary healthcare delivery. Further work is needed to increase patient awareness of the PBP role.

  • general practice
  • general practitioners
  • pharmacists
  • primary health care
  • qualitative interviews

INTRODUCTION

Health workforce shortages and the increasing complexity of caring for older people with chronic conditions have increased pressure on primary care services.1–3 Pharmacists were introduced into general practices to alleviate some of the pressures within primary care (known as practice-based pharmacists; PBPs) by delivering a range of activities.1,3–9 Five-year PBP pilot schemes have been launched in both England and Northern Ireland (NI) to integrate PBPs into general practice.7,10

Most emerging literature has focused on determining barriers and facilitators to the PBP role in general practice; however, there was little detail in relation to the context of the PBP role.11 Additional research was recommended to assess healthcare professionals’ (HCPs) experiences of this new role in general practice and the impact on GP workload.11 Exploring such views on PBPs will enhance the understanding of their impact in primary care and help inform the development of the role.12 Furthermore, the effectiveness of the primary healthcare team is limited by what HCPs know about each other and each other’s roles.13–15

Little is known about the views of key HCPs, particularly GPs and community pharmacists (CPs), regarding the introduction and integration of the PBP role. A previous cross-sectional study conducted by the authors exploring NI GPs’ views on PBPs highlighted some issues in relation to integration and development of the PBP role that merit further examination.4 Therefore, this research aimed to contribute to a comprehensive exploration of GPs’, PBPs’, and CPs’ experiences of working with PBPs, and their views on the integration of PBPs into general practice and their impact on primary healthcare delivery in NI.

METHOD

A qualitative approach to data collection was adopted using semi-structured individual interviews with GPs, PBPs, and CPs across NI. The study was reported according to the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist.16

Study population and setting

The perspectives of three key HCPs (GPs, PBPs, and CPs) practising throughout NI were sought (Box 1). As a result of the COVID- 19 pandemic, interviews were conducted individually, via telephone or a virtual meeting platform such as Microsoft Teams.

Criteria
  • GPs working with PBPs in their general practices.

  • PBPs employed (full time or part time) in one of 17 GP federations in NI (see Supplementary Information S5 for further information about the federations and links with PBPs).

  • CPs who had most contact with general practices in which the recruited GPs and PBPs worked.

  • CP = community pharmacist. NI = Northern Ireland. PBP = practice-based pharmacist.

Box 1.

Inclusion criteria for the three key healthcare professionals — GPs, practice-based pharmacists, and community pharmacists

Sampling and recruitment

Purposive and snowball sampling were used to obtain GPs’, PBPs’, and CPs’ perspectives, and to enhance recruitment. Previous studies have found that, if a general practice agrees to participate in a study, associated community pharmacies will also agree.17,18 Therefore, sampling was initiated by contacting three GPs (known to two of the authors), to ask them to identify potential GPs and PBPs whom they knew and who might be interested in the study. These GPs asked permission from these potential participants to share their contact details with the researcher (the first author). In turn, during the interviews, a recruited GP and PBP were asked to nominate and suggest the name of a potential CP participant with whom the practice had most contact. The researcher contacted that pharmacist using publicly available contact details. Therefore, triads were recruited, each consisting of a GP, PBP, and CP, from across the five Health and Social Care Trust areas in NI (that is, administrative healthcare areas in NI) with a view to recruiting up to three triads per area and one triad per practice.

Little is known about primary healthcare professionals’ views on the impact of practice-based pharmacists (PBPs) in general practice. Participants interviewed in this study reported that PBPs had integrated well and perceived a positive impact on primary healthcare delivery. The findings indicated that continued integration would need PBPs, all members of the practice team, and community pharmacists (CPs) to understand each other’s roles well and to communicate clearly to ensure the delivery of efficient PBP-led patient care. A number of areas for development were identified, such as patient awareness of the role and communication pathways between PBPs and CPs.

How this fits in

The researcher invited potential HCP participants by telephone/email. If interested, the researcher provided a formal invitation letter and information sheet. Interviews were conducted with the GP and PBP within the potential triad when both the GP and PBP agreed to participate. If a CP within a triad did not agree to participate, the GP and PBP interviews were retained for analysis and it was noted that a CP could not be recruited.

Data collection

Interviews were conducted by the researcher between August 2020 and October 2021. Participants provided written informed consent and were offered £50 for participation. Separate topic guides were developed for each HCP group (Supplementary Information S1–S3), based on published literature within the field, and piloted.5,12,19–29 All interviews were audiorecorded with the permission of the participant.

Data management and analysis

All interviews were recorded, transcribed verbatim, and checked for accuracy. To ensure anonymity and confidentiality, each participant was assigned a two-digit identification number reflecting the triad with which the participant was associated (for example Triad 1: GP01, PBP01, CP01). Transcripts were imported and managed in NVivo 12 Pro.

Data analysis, using thematic analysis,30 was performed in parallel with data collection by two independent researchers. Data from interviews with each type of HCP were analysed separately to monitor data saturation within each HCP category. Themes were reviewed and refined by the research team. The quality and rigour of research reporting was closely monitored (Supplementary Table S1).

RESULTS

Eleven triads were recruited from across the five administrative areas (Table 1), at which point data saturation was deemed to have occurred. A CP in one triad from the Western Trust was unable to participate because of COVID-19 vaccination workload; however, the GP and PBP interviews were retained for analysis. Of the 32 interviews conducted, most were undertaken by telephone (n = 22), with the remainder using Microsoft Teams.

View this table:
  • View inline
  • View popup
Table 1.

A summary of the demographic profile of participating GPs, practice-based pharmacists, and community pharmacists

Demographic data

In total, 11 GPs, 11 PBPs, and 10 CPs participated (Table 1). The participants’ demographics demonstrated variety in terms of key characteristics relevant to the research as they were recruited from a range of geographical areas (that is, five administrative areas; see Supplementary Information S4 for more details about demographic data). At the time of the study, most GPs (n = 8, 73%) had two PBPs working part time in their practices. More than half of participating PBPs (n = 6, 55%) had been working as a PBP for >2 years. CPs had been in community practice for an average of 18.1 (standard deviation 11.1) years.

Main themes from thematic analysis

Thematic analysis revealed four main themes in relation to PBPs’ integration into general practices. This study found that the evolution of the role; PBP attributes; collaboration and communication; and impact on care contributed to integration of PBPs into general practice. Furthermore, integration and impact on care were interrelated (as indicated by the double-headed arrow in Figure 1) in that integration led to an impact on care, and impact on care contributed to better integration.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Four main themes that emerged from thematic analysis of interview data. The double- headed arrow indicates that integration led to an impact on care, and impact on care contributed to better integration. PBP = practice-based pharmacist.

Theme 1: evolution of the role

All GPs and PBPs described the wide range of activities undertaken by PBPs that could also differ between practices. They emphasised that the PBP role largely consisted of two main activities: medicines reconciliation of hospital discharge letters and outpatient letters, and medication reviews (see Supplementary Information S5 for definition). The role evolved with time and PBPs began to engage with other tasks, such as independent prescribing and conducting chronic disease review clinics:

‘They have a wide range of roles … they do the medicine reconciliation from the discharge letters, outpatient letters … do medication reviews … so that would be kind of core work in addition to that they do some of the repeat dispensing prescriptions and also some appropriate acute requests … they would do hypertension clinic, diabetes clinics … so it’s a very busy role and I think it’s a very expanding role as well.’

(GP11)

PBPs and GPs reported that conducting chronic disease review clinics (see Supplementary Information S5 for definition) in general practice would continue to be an expanding and evolving role for PBPs, with better integration as they undertook more clinical roles. However, there were workload pressures and time constraints that sometimes prevented this happening, leading to prioritisation of medication reconciliation and medication reviews:

‘I feel practice pharmacists have a very good knowledge base and very good capability and skills to be able to contribute to the long-term management review clinics but sometimes that is not possible because their time is needed elsewhere in the medication reconciliation process and medication reviews in general.’

(PBP05)

PBPs reported that time was wasted doing some administrative tasks that could be passed to pharmacy technicians to allow the PBP to do more clinical work and ultimately achieve better integration:

‘… get away from the hospital letters, start the technician role, get more clinics, see more patients that would be for me a better integration.’

(PBP10)

In addition, GPs revealed that having more full-time PBPs in general practice would allow more activities to be undertaken:

‘Our practice-based pharmacists are busy … I suppose if we could have more full- time pharmacists that would be fantastic … there’s a huge amount of work that could be done.’

(GP06)

Practices used different approaches to decide which activities the PBP would undertake. As PBPs were employed by a federation, this could influence what PBPs did. Participants described that there were ‘two bosses’, ‘a blended approach’, or ‘dual function’ to decide the activities of PBPs within general practices (that is, through the key performance indicators set by the federation and the needs of the practice):

‘Sometimes it can be quite difficult because you nearly have two bosses; you have your federation boss and then you have your practice manager and your lead GP in your doctor surgery.’

(PBP01)

However, some GPs and PBPs believed that practices should have had more input into how they wanted the PBP to work within the practice:

‘Full integration for me would really be where the role of the pharmacist is very much driven by the individual practice … so driving on the structure of the practice.’

(GP05)

Many participants highlighted a lack of awareness of the PBP role by others, including patients as summarised below.

GPs’ awareness of the PBP role

GPs and PBPs emphasised that the PBP role had not been clearly defined at the beginning of the initiative. However, they reported this had evolved and was now much clearer:

‘I think it has become much clearer over time … initially when the practice-based pharmacist was first introduced into the practice, we probably thought [of] some of the things that they could do and then after being with us, we were able to see more and more the value of them.’

(GP08)

Despite this clarity, GPs and PBPs said that the role was not clear to all GPs:

‘Not to all GPs. I think there are some GPs who … do not let them [PBPs] use their skills and their training to their full potential.’

(GP02)

CPs’ awareness of the PBP role

Most PBPs perceived that their role was not entirely clear to CPs; CPs had similar views, but it largely depended on the relationship between the CP and the PBP. CPs’ limited awareness of the role was attributed to the lack of information about a PBP joining a general practice; they only became more aware while working with PBPs on a day-to-day basis:

‘I think sometimes they [CPs] think we don’t do anything … but in a word “no”, I don’t think they know the role.’

(PBP11)

‘I’d say it’s not entirely clear … I’m not entirely sure of the role.’

(CP11)

‘… we actually built relationships … I think that helped community pharmacists realise what we do.’

(PBP10)

‘I don’t think we have been like that for example given any further information regarding what practice pharmacists work where and when … now we can hear what they do from day to day and their roles certainly but probably not initially.’

(CP04)

Patients’ awareness of the PBP role

Most participants believed that patients were largely unaware of the PBP role and did not understand the difference between CPs and PBPs (that is, patients might think that the PBP worked in community pharmacy and did not realise that there was a pharmacist based in the practice):

‘A lot of patients are not familiar that we have maybe [a] pharmacist in the practice … I think a lot of them would not really differentiate between practice pharmacists and community pharmacists.’

(GP02)

‘A lot of patients are unaware that practices have practice-based pharmacists, and they think sometimes the practice pharmacist is just someone that works in community pharmacy and provides a prescription …’

(PBP07)

‘I would say probably not … you would still have patients that maybe don’t realise that there is a pharmacist based in the surgery …’

(CP05)

Most GPs and PBPs felt that full integration of PBPs into general practice and promotion of the role would lead to greater awareness so that, in the future, patients could contact the practice to speak to a pharmacist about an acute problem or the practice team could refer patients to the PBP when appropriate rather than to the GP:

‘So full integration to me would be … they [patients] know what we exactly do, what our role is, and that we’re there to help them and they don’t necessarily need to always speak to GP about an issue.’

(PBP03)

Theme 2: PBP attributes

Participating GPs and PBPs reported that communication skills were essential for PBPs to undertake their role. Other useful skills related to: consultations, teamwork and leadership, independent working, time management, and information technology functions:

‘They need good communication skills as they are quite a link between everybody … skills would be team working skills, leadership skills, and independent working skills … consultation skills with dealing with the huge variety of the general public …’

(GP06)

Furthermore, a number of GPs and PBPs revealed that PBPs would need clinical skills to allow them to undertake their role and would need the confidence to be able to use these skills:

‘… they need to have basic clinical skills such as being able to take blood pressure …’

(GP07)

‘You need like clinical skills to make sure that you’re doing things safely and we need to have the confidence to be able to check hospital medications as well as community medications …’

(PBP06)

All participating PBPs had previous experience of working in community pharmacy, which was beneficial in understanding how community pharmacy operated and the importance of having good communication skills:

‘Because I have experience in community pharmacy, I felt confident with what I do now, so I felt confident coming into that role, so certainly having … good communications with both patients and the multidisciplinary team.’

(PBP08)

However, all PBPs indicated that there were more opportunities to develop and acquire new skills, including practice-based learning compared with when working in a community pharmacy, and, therefore, they were more satisfied with the PBP role:

‘I think a lot of the people in the post really enjoy it … there are more training opportunities, more development opportunities … a lot of them have moved from community pharmacy and wanted a change … or better work–life balance.’

(PBP09)

Several GPs and PBPs believed that it would be very beneficial for the PBP to be an independent prescriber. It was noted that the PBPs who were independent prescribers saved GP time because of reduced duplication of work. Moreover, this qualification enhanced PBPs’ confidence and experience:

‘… that saves us [GPs] a lot of time … there was a lot of duplication of work when he [PBP] wasn’t able to prescribe …’

(GP01)

‘Everyone needs independent prescribing … it’s about building up the level of confidence and experience …’

(PBP06)

Theme 3: collaboration and communication

Participants emphasised that teamwork, supported by clear communication and strong relationships, would be key to achieving collaboration. Trust in, and mutual respect for, each HCP’s expertise and individual skills were also reported as factors to facilitate relationship building and, thus, achieving and enhancing collaborative work:

‘Interprofessional collaboration would mean communication, having a good relationship … developing trust in the people that you’re working with. I do think that’s the way we work here, it’s very much respectful … so that helps enhance team spirit; feeling that everyone is working within a team.’

(GP06)

Participants reported several benefits of collaboration between GPs, PBPs, and CPs: streamlining healthcare delivery, reduction in duplication of effort, rapid response to each HCP, and improved patient outcomes and safety:

‘Ultimately collaboration will seek to reduce duplication of effort and ultimately, if we’re working together synergistically for the patient, that will improve patient outcomes … it streamlines everything … and things are done so much quicker …’

(PBP10)

Most GPs and PBPs identified that having more formal meetings, involving the PBP in practice meetings and social activities, having full-time PBP positions in the general practice, and having designated times to communicate and to meet regularly would enhance communication, working relationships, and consequently achieve better integration:

‘It [full integration of PBPs] is very much focused on regular meetings and to make that protected time for the pharmacist to meet with all members of the team.’

(GP03)

‘… as long as pharmacists are involved in practice meetings and decisions and have those relationships, I think there’s not much more that could be done.’

(PBP09)

Further details on the impact of full- time PBP positions on integration are given below.

Development of relationships across the practice team and with patients

Many GPs and PBPs described the importance of having full-time PBP positions in the general practice to develop relationships across the practice team as well as between the PBP and patients:

‘… each time that a practice pharmacist has come to our practice, we have spent time developing these relationships and then, unfortunately, sometimes they’ve had to move on … and sometimes there’s a reluctance to invest time unless you’re sure that the pharmacist that you’re getting is going to be there for long term.’

(GP07)

‘… being permanently employed within a practice is key … it [PBP role] needs to be a permanent role … so that GPs get what they want from practice-based pharmacists … and practice-based pharmacists can develop relationships with GPs and patients within the practice as well …’

(PBP02)

Completion of PBPs’ tasks

A number of PBPs highlighted the difficulties of covering too many practices and the effect on some tasks, for example, following up hospital letters:

‘… you would find it kind of hard to sort of go to one surgery one day and then go to another surgery the next day, we need to be able to build up relationship with other workers in the primary care team, but also be able to build it up with patients, and also some following up things, it just kind of sort of the hospital letters when you are and then that’s you move on to the next surgery …’

(PBP03)

The response to CPs’ queries

Some CPs described occasional delays in response if a PBP was not in the practice on a full-time basis:

‘… I have noticed that you know a surgery with a practice-based pharmacist, you get [a] response much quicker, whereas compared to a surgery that wouldn’t have one or the practice-based pharmacist doesn’t work that day, there will be delay sometimes.’

(CP04)

PBPs were considered to be in a perfect position to link between different professionals and to act as the first point of contact in general practice for CPs. Many saw PBPs as a ‘central hub–middleman’ between general practice and community pharmacies and between primary and secondary care. CPs felt that it was easier to communicate with the PBP as opposed to GPs who had historically dealt with queries from CPs:

‘I’m sort of the middleman … I pass all that information into our community pharmacy to make sure that they can order the right items for the patient …’

(PBP01)

‘We don’t speak to the GP as much … but they’re [PBPs] more the middleman now …’

(CP10)

‘Practice-based pharmacists can respond to queries often quicker and more efficient …’

(CP05)

Participants emphasised the need to have direct access to the PBP (for example, direct telephone line/email) to improve communication:

‘We don’t have direct access to speak with the practice pharmacist … the best way for them [practices] to do this would [be to] have a dedicated phone line for the practice-based pharmacist.’

(CP07)

Participants noted that having shared education, training, and meetings among the multidisciplinary team and involving CPs would be essential to ensure that all HCPs would adhere to the same principles and procedures in patient care. Participants indicated that these activities would contribute to good working relationships, improve collaboration and communication, and increase HCPs’ awareness of the PBP role:

‘I suppose if we have time to maybe do teaching or learning together, I suppose that would be really helpful … we could all know that we’re all doing the same thing …’

(GP10)

‘I think it’s a fantastic idea where you have multidisciplinary groups in the same table … I might bring to the table something that the others don’t, and the others obviously bring something there I don’t see.’

(CP07)

PBPs emphasised that better collaboration and communication would be achieved by increasing primary care team members’ awareness and patients’ awareness of the PBP role:

‘I think education is number one there … I think as a first and foremost educating the main people about the role for example GPs. I think that improves the interprofessional sort of collaboration and communication.’

(PBP01)

Theme 4: impact on care

GPs and PBPs reported that PBPs reduced GPs’ workload and saved time by conducting activities previously performed by GPs. As a result, this provided the GP with more time to see patients, resulting in better patient care:

‘They [PBPs] have given us more time … we’re not trying to terminate the consultation in order to do the huge pile of paperwork so we can do more work directly with the patient … and that the patient will get the benefit of that.’

(GP06)

Furthermore, GPs indicated that PBPs were an invaluable source of information, ensuring that GPs were aware of the most current guidelines.

‘They [PBPs] are a great source of information … they are able to sit down and look at the drugs and really take the time to go through them properly … they are very up to date as well on the guidelines, as well quite a lot of time they are keeping us up to date with the guidelines …’

(GP10)

GPs and PBPs also reported that PBPs’ activities enhanced patient safety as they had more time to focus on hospital discharge letters, chronic disease review clinics, and queries from community pharmacies and secondary care. These activities reduced interruptions experienced by GPs during their work and ultimately reducing the risk of errors. GPs also reported that the PBP was detail oriented:

‘It has made our life better and safer and more pleasant … it has done that for me when you’re coming into a busy day and they’re at the end of it, you have maybe got sixty letters to process, you know, mistakes are going to be made with tiredness and with just too much volume of stuff … so there’s attention to detail and having a bit more time …’

(GP03)

Participants indicated that the PBP had a critical role in medicines optimisation, particularly for the older population who were at higher risk of adverse drug events and those with polypharmacy:

‘I feel like medicines optimisation is kind of our main role … our medication review specifically wants to focus on those patients with polypharmacy … those that are frail and elderly …’

(PBP06)

DISCUSSION

Summary

This qualitative study highlighted that the PBP role had evolved since its introduction across general practice in NI and the PBP role has had a positive impact on GPs, CPs, and patients. Insights were provided into participants’ views on what had contributed to integration (for example, a good GP–PBP collaboration) as well as aspects that required further attention (for example, patients’ awareness of the role) to ensure better and continuing integration of PBPs into general practice.

Strengths and limitations

The qualitative design and the triad approach provided a more comprehensive overview of the working relationships between the three HCP groups and allowed for an in-depth and thorough understanding of participants’ views. Data were analysed independently by two researchers and decisions were made on the themes through a consensus approach, enhancing the trustworthiness of the findings and in accordance with the COREQ checklist.16

A number of limitations should be noted. First, recruitment was limited to one UK geographical region. Most participants were recruited through snowball sampling that may have introduced potential bias. No PBPs were interviewed who had previously worked in hospital pharmacy (that is, all had a community pharmacy experience), which could affect the transferability of the findings. However, despite this, three key HCPs from different NI trust areas were included and their perspectives are broadly similar to those reported in the literature, thereby reinforcing the transferability of these findings.

Comparison with existing literature

In this study, it was apparent that the PBP role varied between practices and there were several activities undertaken by PBPs that have previously been identified.12,24,26,31–40 However, insufficient time and current workload were perceived as barriers to undertaking some activities and have been noted in other research.23,34,38,39 Integrating pharmacy technicians into general practice was suggested as a way to save PBP time to conduct more clinical work and thus make better use of PBP skills. Previous studies have shown that there is the potential to expand the role of pharmacy technicians in the UK to become more involved in the future delivery of medication reviews.39–41

Lack of patient awareness of the role was highlighted by nearly all participants. As the PBP role was relatively new and varied between GP practices, participants believed that patients did not understand the difference between CPs and PBPs, which is consistent with other studies.21,25,42–44 Nearly all participants in the current study emphasised the need to properly inform patients and primary care team members about PBPs, including roles and responsibilities, to raise patients’ awareness and therefore encourage the uptake of PBPs’ services, ultimately leading to better integration of the PBP.20,34,38,39,42,44 Further work to explore patients’ understanding and views of the PBP role in general practice is necessary to corroborate the participants’ concerns in the current study.

Awareness of the PBP role was one of the key aspects that requires further attention to achieve better integration. This current study indicates that, although most GPs were aware of the role, participants reported that a minority were not. Furthermore, the PBP role was not entirely clear to CPs, which has been previously reported.21,45 Clearly defined roles improve collaboration and decrease misunderstandings about responsibilities and authority.46–48 Consistent with the findings in this study, previous studies highlighted that scheduling meetings with individual team members was a common approach to informing the team about the role.49,50

Having full-time PBPs was described as a way to enhance communication. Many highlighted the advantage of having a full-time PBP to build and develop strong relationships and ultimately better integration into a team. This has been reported elsewhere.23,24,33,34 Working across many practices could possibly lead to a lack of continuity, thus hindering integration,11,40 while also having an impact on tasks such as managing repeat medication re-authorisation.39 A previous study found that patients reported difficulties in arranging appointments with PBPs who covered multiple practices.23,42

The findings of this current study have indicated that PBPs are ideally placed to use their skills and knowledge to help the GP practices and liaise with CPs. Evidence has shown that PBPs provide valuable services to ease the burden on the GP and reduce patient waiting times.51–53 In the current study, it was perceived that PBPs had an impact not only on GP workload but also on patient safety and care, and medicines optimisation. These are reassuring findings as, for example, 20% of hospital admissions among older people are the result of adverse effects of prescribed medications.54

Implications for practice

There are a number of recommendations for practices based on the results of this study. As the role of the PBP is expected to expand to include more clinical patient-facing roles, pharmacists must be prepared for this. New standards for the initial education and training of pharmacists across the UK have been recently introduced, for example, qualified to undertake independent prescribing from the point of registration.55 Furthermore, this study revealed that PBPs would need clinical skills to allow them to undertake their role and would need the confidence to be able to use these skills. A recently published Delphi study has produced a core set of clinical skills required for pharmacist prescribers working in general practice that could inform training.56 However, expansion of the role and increasing patient awareness of the role may exacerbate workload issues. Therefore, having more PBPs and pharmacy technicians in general practice may help to address these demands.

A number of policies have been launched in the UK to expand the current integration of PBPs in general practice.57–59 Therefore, the findings from this study provide valuable insights for policymakers, practice managers, and service commissioners into what is required to ensure better, efficient, and smooth integration of PBPs. The findings from this study may be useful in countries where consideration is being given to the development of pharmacist services in general practice.

Acknowledgments

The authors gratefully acknowledge the input from all GPs, PBPs, and CPs who participated in the interviews. The authors would also like to thank the GPs, the PBPs, and the pharmacists for their feedback on the interview topic guides. The authors are grateful to the GPs who helped to initiate recruitment.

Notes

Funding

This study was supported by Al-Zaytoonah University of Jordan in Jordan. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or in the decision to submit the paper.

Ethical approval

The study received ethical approval from the Faculty of Medicine, Health and Life Sciences Research Ethics Committee, Queen’s University Belfast, on 4 August 2020 (Reference MHLS 20_96).

Provenance

Freely submitted; externally peer reviewed.

Competing interests

The authors have declared no competing interests.

Discuss this article

Contribute and read comments about this article: bjgp.org/letters

  • Received October 18, 2022.
  • Revision requested December 2, 2022.
  • Accepted February 14, 2023.
  • © The Authors
http://creativecommons.org/licenses/by/4.0/

This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/).

REFERENCES

  1. 1.↵
    1. Baird B,
    2. Charles A,
    3. Honeyman M,
    4. et al.
    (2016) Understanding pressures in general practice, https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/Understanding-GP-pressures-Kings-Fund-May-2016.pdf (accessed 24 Apr 2023).
  2. 2.
    1. Al-Qerem W,
    2. Jarrar YB,
    3. Al-Sheikh I,
    4. Elmaadani A
    (2018) The prevalence of drug-drug interactions and polypharmacy among elderly patients in Jordan. Biomed Res 29, 12, 2561–2569.
    OpenUrl
  3. 3.↵
    1. Maskrey M,
    2. Johnson CF,
    3. Cormack J,
    4. et al.
    (2018) Releasing GP capacity with pharmacy prescribing support and New Ways of Working: a prospective observational cohort study. Br J Gen Pract, https://doi.org/10.3399/bjgp18X699137.
  4. 4.↵
    1. Hasan Ibrahim A,
    2. Barry H,
    3. Hughes C
    (2022) General practitioners’ experiences with, views of, and attitudes towards, general practice-based pharmacists: a cross-sectional survey. BMC Prim Care 23, 6.
    OpenUrl
  5. 5.↵
    1. Hasan Ibrahim AS,
    2. Barry HE,
    3. Hughes CM
    (2021) A systematic review of general practice-based pharmacists’ services to optimize medicines management in older people with multimorbidity and polypharmacy. Fam Pract 38, 4, 509–523.
    OpenUrl
  6. 6.
    1. Gillespie U,
    2. Dolovich L,
    3. Dahrouge S
    (2017) Activities performed by pharmacists integrated in family health teams: results from a web-based survey. Can Pharm J 150, 6, 407–416.
    OpenUrl
  7. 7.↵
    1. NHS England
    Clinical pharmacists, No date. https://www.england.nhs.uk/gp/gpfv/workforce/building-the-general-practice-workforce/cp-gp/ (accessed 24 Apr 2023).
  8. 8.
    1. Chopra E,
    2. Choudhary T,
    3. Hazen A,
    4. et al.
    (2022) Clinical pharmacists in primary care general practices: evaluation of current workforce and their distribution. J Pharm Policy Pract 15, 101.
    OpenUrl
  9. 9.↵
    1. Iqbal N,
    2. Huynh C,
    3. Maidment I
    (2022) Systematic literature review of pharmacists in general practice in supporting the implementation of shared care agreements in primary care. Syst Rev 11, 88.
    OpenUrl
  10. 10.↵
    1. Strategic Leadership Group for Pharmacy
    (2016) Practice based pharmacists, https://www.health-ni.gov.uk/sites/default/files/publications/health/practice-based-pharmacists.pdf (accessed 24 Apr 2023).
  11. 11.↵
    1. Anderson C,
    2. Zhan K,
    3. Boyd M,
    4. Mann C
    (2019) The role of pharmacists in general practice: a realist review. Res Soc Adm Pharm 15, 4, 338–345.
    OpenUrl
  12. 12.↵
    1. Hampson N,
    2. Ruane S
    (2019) The value of pharmacists in general practice: perspectives of general practitioners — an exploratory interview study. Int J Clin Pharm 41, 2, 496–503.
    OpenUrlPubMed
  13. 13.↵
    1. Hughes CM,
    2. McCann S
    (2003) Perceived interprofessional barriers between CPs and general practitioners: a qualitative assessment. Br J Gen Pract 53, 493, 600–606.
    OpenUrlAbstract/FREE Full Text
  14. 14.
    1. MacDonald MB,
    2. Bally JM,
    3. Ferguson LM,
    4. et al.
    (2010) Knowledge of the professional role of others: a key interprofessional competency. Nurse Educ Pract 10, 4, 238–242.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Brown J,
    2. Lewis L,
    3. Ellis K,
    4. et al.
    (2011) Conflict on interprofessional primary health care teams — can it be resolved? J Interprof Care 25, 1, 4–10.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Tong A,
    2. Sainsbury P,
    3. Craig J
    (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Heal Care 19, 6, 349–357.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Hughes CM,
    2. Goldie R
    (2009) ‘I just take what I am given’: adherence and resident involvement in decision making on medicines in nursing homes for older people: a qualitative survey. Drugs Aging 26, 6, 505–517.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Rubio-Valera M,
    2. Jové AM,
    3. Hughes CM,
    4. et al.
    (2012) Factors affecting collaboration between general practitioners and community pharmacists: a qualitative study. BMC Health Serv Res 12, 188.
    OpenUrlPubMed
  19. 19.↵
    1. Baker S,
    2. Lee YP,
    3. Hattingh HL
    (2019) An evaluation of the role of practice pharmacists in Australia: a mixed methods study. Int J Clin Pharm 41, 2, 504–515.
    OpenUrl
  20. 20.↵
    1. Karampatakis GD,
    2. Ryan K,
    3. Patel N,
    4. et al.
    (2019) How do pharmacists in English general practices identify their impact? An exploratory qualitative study of measurement problems. BMC Health Serv Res 19, 34.
    OpenUrl
  21. 21.↵
    1. Barry H,
    2. Clarke R,
    3. Hughes C
    (2020) Community pharmacists’ experiences with, views of, and attitudes towards general practice-based pharmacists: a cross-sectional survey study. Int J Pharm Pract 28, S1, 31.
    OpenUrl
  22. 22.
    1. Freeman C,
    2. Cottrell WN,
    3. Kyle G,
    4. et al.
    (2012) Pharmacists’, general practitioners’ and consumers’ views on integrating pharmacists into general practice. J Pharm Pract Res 42, 3, 184–188.
    OpenUrl
  23. 23.↵
    1. Tan ECK,
    2. Stewart K,
    3. Elliott RA,
    4. George J
    (2013) Stakeholder experiences with general practice pharmacist services: a qualitative study. BMJ Open 3, 9, e003214.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Tan ECK,
    2. Stewart K,
    3. Elliott RA,
    4. George J
    (2014) Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists. Int J Pharm Pract 22, 1, 28–37.
    OpenUrlPubMed
  25. 25.↵
    1. Bajorek B,
    2. Lemay K,
    3. Gunn K,
    4. Armour C
    (2015) The potential role for a pharmacist in a multidisciplinary general practitioner super clinic. AMJ 8, 2, 52–63.
    OpenUrl
  26. 26.↵
    1. Mann C,
    2. Anderson C,
    3. Avery A,
    4. et al.
    (2018) Clinical pharmacists in general practice: pilot scheme Independent evaluation report, https://www.nottingham.ac.uk/pharmacy/documents/generalpracticeyearfwdrev/clinical-pharmacists-in-general-practice-pilot-scheme-full-report.pdf (accessed 24 Apr 2023).
  27. 27.
    1. Butterworth J,
    2. Sansom A,
    3. Sims L,
    4. et al.
    (2017) Pharmacists’ perceptions of their emerging general practice roles in UK primary care: a qualitative interview study. Br J Gen Pract, https://doi.org/10.3399/bjgp17X691733.
  28. 28.
    1. Dolovich L,
    2. Pottie K,
    3. Kaczorowski J,
    4. et al.
    (2008) Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther 83, 6, 913–917.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Jorgenson D,
    2. Laubscher T,
    3. Lyons B,
    4. Palmer R
    (2014) Integrating pharmacists into primary care teams: barriers and facilitators. Int J Pharm Pract 22, 4, 292–299.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Braun V,
    2. Clarke V
    (2006) Using thematic analysis in psychology. Qual Res Psychol 3, 2, 77–101.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Benson H,
    2. Lucas C,
    3. Benrimoj SI,
    4. Williams KA
    (2019) The development of a role description and competency map for pharmacists in an interprofessional care setting. Int J Clin Pharm 41, 2, 391–407.
    OpenUrl
  32. 32.
    1. Hurley E,
    2. Gleeson LL,
    3. Byrne S,
    4. et al.
    (2022) General practitioners’ views of pharmacist services in general practice: a qualitative evidence synthesis. Fam Pract 39, 4, 735–746.
    OpenUrl
  33. 33.↵
    1. Deeks LS,
    2. Kosari S,
    3. Naunton M,
    4. et al.
    (2018) Stakeholder perspectives about general practice pharmacists in the Australian Capital Territory: a qualitative pilot study. Aust J Prim Health 24, 3, 263–272.
    OpenUrl
  34. 34.↵
    1. Ryan K,
    2. Patel N,
    3. Lau WM,
    4. et al.
    (2018) Pharmacists in general practice: a qualitative interview case study of stakeholders’ experiences in a West London GP federation. BMC Health Serv Res 18, 1, 234.
    OpenUrlCrossRefPubMed
  35. 35.
    1. James O,
    2. Cardwell K,
    3. Moriarty F,
    4. et al.
    (2020) Pharmacists in general practice: a qualitative process evaluation of the general practice pharmacist (GPP) study. Fam Pract 37, 5, 711–718.
    OpenUrl
  36. 36.
    1. Pottie K,
    2. Farrell B,
    3. Haydt S,
    4. et al.
    (2008) Integrating pharmacists into family practice teams: physicians’ perspectives on collaborative care. Can Fam Physician 54, 12, 1714.
    OpenUrlAbstract/FREE Full Text
  37. 37.
    1. Bradley F,
    2. Seston E,
    3. Mannall C,
    4. Cutts C
    (2018) Evolution of the general practice pharmacist’s role in England: a longitudinal study. Br J Gen Pract, https://doi.org/10.3399/bjgp18X698849.
  38. 38.↵
    1. Alshehri AA,
    2. Cheema E,
    3. Yahyouche A,
    4. et al.
    (2021) Evaluating the role and integration of general practice pharmacists in England: a cross-sectional study. Int J Clin Pharm 43, 1609–1618.
    OpenUrl
  39. 39.↵
    1. Savickas V,
    2. Foreman E,
    3. Ladva A,
    4. et al.
    (2021) Pharmacy services and role development in UK general practice: a cross-sectional survey. Int J Pharm Pract 29, 1, 37–44.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Stewart D,
    2. Maclure K,
    3. Newham R,
    4. et al.
    (2020) A cross-sectional survey of the pharmacy workforce in general practice in Scotland. Fam Pract 37, 2, 206–212.
    OpenUrlPubMed
  41. 41.↵
    1. Boughen M,
    2. Sutton J,
    3. Fenn T,
    4. Wright D
    (2017) Defining the role of the pharmacy technician and identifying their future role in medicines optimisation. Pharm 5, 3, 40.
    OpenUrl
  42. 42.↵
    1. Karampatakis GD,
    2. Patel N,
    3. Stretch G,
    4. Ryan K
    (2021) Patients’ experiences of pharmacists in general practice: an exploratory qualitative study. BMC Fam Pract 22, 48.
    OpenUrlCrossRefPubMed
  43. 43.
    1. Benson H,
    2. Sabater-Hernández D,
    3. Benrimoj SI,
    4. Williams KA
    (2018) Piloting the integration of non-dispensing pharmacists in the Australian general practice setting: a process evaluation. Int J Integr Care 18, 2, 4.
    OpenUrlPubMed
  44. 44.↵
    1. Mann C,
    2. Anderson C,
    3. Boyd M,
    4. et al.
    (2022) Perspectives of pharmacists in general practice from qualitative focus groups with patients during a pilot study. BJGP Open, https://doi.org/10.3399/BJGPO.2021.0112.
  45. 45.↵
    1. Karampatakis GD,
    2. Patel N,
    3. Stretch G,
    4. Ryan K
    (2020) Community pharmacy teams’ experiences of general practice-based pharmacists: an exploratory qualitative study. BMC Health Serv Res 20, 431.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Zillich AJ,
    2. McDonough RP,
    3. Carter BL,
    4. Doucette WR
    (2004) Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 38, 5, 764–770.
    OpenUrlCrossRefPubMed
  47. 47.
    1. Farrell B,
    2. Dolovich L,
    3. Austin Z,
    4. Connie S
    (2010) Implementing a mentorship program for pharmacists integrating into family practice: practical experience from the IMPACT project team. Can Pharm J 143, 1, 28–36.
    OpenUrl
  48. 48.↵
    1. Jorgenson D,
    2. Dalton D,
    3. Farrell B,
    4. et al.
    (2013) Guidelines for pharmacists integrating into primary care teams. Can Pharm J 146, 6, 342–352.
    OpenUrl
  49. 49.↵
    1. Farrell B,
    2. Pottie K,
    3. Haydt S,
    4. et al.
    (2008) Integrating into family practice: the experiences of pharmacists in Ontario, Canada. Int J Pharm Pract 16, 5, 309–315.
    OpenUrlCrossRef
  50. 50.↵
    1. Kolodziejak L,
    2. Rémillard A,
    3. Neubauer S
    (2010) Integration of a primary healthcare pharmacist. J Interprof Care 24, 3, 274–284.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Avery AJ
    (2017) Pharmacists working in general practice: can they help tackle the current workload crisis? Br J Gen Pract, https://doi.org/10.3399/bjgp17X692201.
  52. 52.
    1. Roland M,
    2. Everington S
    (2016) Tackling the crisis in general practice. BMJ 352, i942.
    OpenUrlFREE Full Text
  53. 53.↵
    1. Mann C,
    2. Anderson C,
    3. Boyd M
    (2022) The role of clinical pharmacists in general practice in England: impact, perspectives, barriers and facilitators. Res Soc Adm Pharm 18, 8, 3432–3437.
    OpenUrl
  54. 54.↵
    1. Mir FA,
    2. Morgan L,
    3. Houghton E
    (2021) Tackling overprescribing. BMJ 375, n2539.
    OpenUrlFREE Full Text
  55. 55.↵
    1. General Pharmaceutical Council
    (2021) Standards for the initial education and training of pharmacists — interim learning outcomes, https://www.pharmacyregulation.org/sites/default/files/document/interim-learning-outcomes-foundation-training-year-march-2021.pdf (accessed 24 Apr 2023).
  56. 56.↵
    1. Hasan Ibrahim AS,
    2. Barry HE,
    3. Girvin B,
    4. Hughes CM
    (2023) Development of a core set of clinical skills for pharmacist prescribers working in general practice: a Delphi study. Res Soc Adm Pharm, https://doi.org/10.1016/j.sapharm.2023.01.002.
  57. 57.↵
    1. NHS England
    (2017) General practice forward view (GPFV) clinical pharmacists in general practice phase 2 guidance for applicants, https://www.england.nhs.uk/publication/gpfv-clinical-pharmacists-gp-phase-2-guidance-for-applicants/ (accessed 24 Apr 2023).
  58. 58.
    1. Scottish Government
    (2013) Prescription for excellence — the future of pharmaceutical care: vision and plan, https://www.gov.scot/publications/prescription-excellence-vision-action-plan-right-pharmaceutical-care-through-integrated-partnerships-innovation/ (accessed 24 Apr 2023).
  59. 59.↵
    1. Health and Social Care Board
    (2019) Investment in GP practices, https://online.hscni.net/our-work/gps/investment-in-gp-practices/ (accessed 24 Apr 2023).
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 73 (731)
British Journal of General Practice
Vol. 73, Issue 731
June 2023
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
GPs’ and pharmacists’ views of integrating pharmacists into general practices: a qualitative study
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
GPs’ and pharmacists’ views of integrating pharmacists into general practices: a qualitative study
Ameerah S Hasan Ibrahim, Heather E Barry, Carmel M Hughes
British Journal of General Practice 2023; 73 (731): e407-e417. DOI: 10.3399/BJGP.2022.0518

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
GPs’ and pharmacists’ views of integrating pharmacists into general practices: a qualitative study
Ameerah S Hasan Ibrahim, Heather E Barry, Carmel M Hughes
British Journal of General Practice 2023; 73 (731): e407-e417. DOI: 10.3399/BJGP.2022.0518
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Abstract
    • INTRODUCTION
    • METHOD
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Notes
    • REFERENCES
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • general practice
  • general practitioners
  • pharmacists
  • primary health care
  • qualitative interviews

More in this TOC Section

  • General practice as a place to receive help for domestic abuse during the COVID-19 pandemic: a qualitative interview study in England and Wales
  • Understanding primary care perspectives on supporting women’s health needs: a qualitative study
  • Inequities in hypertension management: observational cross-sectional study in North East London using electronic health records
Show more Research

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

Tweets by @BJGPjournal

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242